Patents by Inventor Jane Elizabeth Clarkson

Jane Elizabeth Clarkson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230279089
    Abstract: Provided herein are antigen binding proteins that specifically bind to BMP1, TLL1 and/or TLL2. Also provided are pharmaceutical compositions containing the antigen binding proteins. The antigen binding proteins and pharmaceutical compositions described herein can be used to treat diseases associated with fibrotic conditions or disorders as well as to promote muscle growth and improve muscle function.
    Type: Application
    Filed: July 29, 2021
    Publication date: September 7, 2023
    Inventors: Jane Elizabeth CLARKSON, Caroline J. DIMECH, Mark R. HARPEL, Carol A. HARRIS, Jian ZHANG
  • Publication number: 20120128689
    Abstract: The present invention relates to antigen binding proteins to human IL-23, pharmaceutical formulations containing them and to the use of such antigen binding proteins in the treatment and/or prophylaxis of inflammatory diseases such as Rheumatoid Arthritis (RA).
    Type: Application
    Filed: March 30, 2010
    Publication date: May 24, 2012
    Applicant: Glaxo Group Limited
    Inventors: Jane Elizabeth Clarkson, Ruth McAdam, Alan Peter Lewis
  • Publication number: 20110206686
    Abstract: The present invention relates to antigen binding proteins to human IL-23, pharmaceutical formulations containing them and to the use of such antigen binding proteins in the treatment and/or prophylaxis of inflammatory diseases such as Rheumatoid Arthritis (RA).
    Type: Application
    Filed: October 3, 2008
    Publication date: August 25, 2011
    Inventors: Gary Peter Bembridge, Jane Elizabeth Clarkson, Jonathan Henry Ellis, Paul Andrew Hamblin, George Kopsidas, Alan Peter Lewis, Ruth Mcadam
  • Publication number: 20090123479
    Abstract: The present invention relates to antigen binding proteins to human IL-23, pharmaceutical formulations containing them and to the use of such antigen binding proteins in the treatment and/or prophylaxis of inflammatory diseases such as Rheumatoid Arthritis (RA).
    Type: Application
    Filed: October 3, 2008
    Publication date: May 14, 2009
    Inventors: Gary Peter Bembridge, Jane Elizabeth Clarkson, Jonathan Henry Ellis, Paul Andrew Hamblin, George Kopsidas, Alan Peter Lewis, Ruth McAdam